* Regulatory evaluation successfully completed * Green light for the test panel to begin its work * ...
We update our fair value range to SEK 93-155 (75-125) with a new mid-point of SEK 124 (100) ahead of...
Ependion’s Q4 report was a bit weaker than we hoped for on sales and earnings.
Ahead of Suominen's Q4 report, we maintain our estimates intact.
* Softer Q4 numbers due to postponed orders... * ..
* Q4 figures in line with pre-announcement * We cut '26e-'27e sales by 6-5%, EBIT positive in '27e (...
We leave our DCF-derived fair equity value range of SEK 129-174 unchanged ahead Duni’s Q4 report.
Plejd levererade ett rekordstarkt fjärde kvartal med en nettoomsättning om 288,3 MSEK (204,0), motsv...
Truecaller released preliminary Q4 2025 numbers this morning.
Today, Cantargia announced the recruitment of the first patient in a new study of nadunolimab in col...
Suominen reports Q4 results on Jan 29. FY’26 should see better earnings, yet growth may still be har...
Redeye leaves a comment following OncoZenge’s announcement of a SEK5m bridge financing via a convert...
* Mild winter in Q4, but sequentially easing comps: organic growth -1% * Cost savings took effect in...
* AI should drive data storage demand, but RAM prices are an issue * Small reductions to estimates, ...
Redeye provides commentary on NextCell following the announcement of a SEK15m directed issue and a s...
* Q4e sales SEK 22m (21m), EBIT adj. SEK -5.5m (-6.
Redeye initiates coverage of Coffee Stain Group, a Swedish game development company recognised for i...
Fiskars has been suffering from weak consumer demand for the past three years.
Redeye comments on Avensia’s December sales figures.
Redeyes shares its preview of Xvivo’s Q4 2025 results, due on January 27.
